VOYA Investment Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.34M Buy
91,636
+174
+0.2% +$14.3K 0.01% 710
2025
Q4
$7.8M Sell
91,462
-10,238
-10% -$840K 0.01% 716
2025
Q3
$7.91M Sell
101,700
-901,057
-90% -$70.4M 0.01% 729
2025
Q2
$78.4M Buy
1,002,757
+56,220
+6% +$4.19M 0.08% 251
2025
Q1
$68.6M Sell
946,537
-389,401
-29% -$27.9M 0.08% 262
2024
Q4
$98.9M Sell
1,335,938
-576,083
-30% -$40.3M 0.1% 220
2024
Q3
$126M Sell
1,912,021
-1,287,592
-40% -$93.5M 0.13% 190
2024
Q2
$296M Sell
3,199,613
-132,220
-4% -$11.7M 0.29% 70
2024
Q1
$318M Buy
3,331,833
+3,051,464
+1,088% +$256M 0.31% 74
2023
Q4
$21.4M Buy
280,369
+5,043
+2% +$351K 0.02% 506
2023
Q3
$19.1M Sell
275,326
-4,293
-2% -$345K 0.02% 511
2023
Q2
$26.4M Buy
279,619
+14,592
+6% +$1.27M 0.03% 463
2023
Q1
$21.9M Buy
265,027
+7,619
+3% +$599K 0.02% 511
2022
Q4
$19.2M Sell
257,408
-953,167
-79% -$73.5M 0.02% 548
2022
Q3
$100M Sell
1,210,575
-8,015
-0.7% -$771K 0.12% 209
2022
Q2
$116M Buy
1,218,590
+917,906
+305% +$95M 0.29% 83
2022
Q1
$35.4M Sell
300,684
-9,164
-3% -$1.03M 0.07% 224
2021
Q4
$40.1M Buy
309,848
+27,769
+10% +$3.24M 0.08% 219
2021
Q3
$31.9M Buy
282,079
+9,882
+4% +$1.13M 0.06% 227
2021
Q2
$28.2M Sell
272,197
-92,359
-25% -$8.71M 0.05% 252
2021
Q1
$30.5M Sell
364,556
-38,083
-9% -$3.22M 0.06% 239
2020
Q4
$36.7M Buy
402,639
+2,206
+0.6% +$183K 0.07% 223
2020
Q3
$32M Buy
400,433
+76,989
+24% +$6.01M 0.07% 228
2020
Q2
$22.4M Buy
323,444
+18,617
+6% +$1.32M 0.05% 294
2020
Q1
$19.2M Buy
304,827
+11,289
+4% +$814K 0.05% 303
2019
Q4
$22.8M Buy
293,538
+43,413
+17% +$3.39M 0.05% 335
2019
Q3
$18.3M Sell
250,125
-243
-0.1% -$17.1K 0.04% 412
2019
Q2
$15.4M Sell
250,368
-1,930,455
-89% -$117M 0.03% 467
2019
Q1
$139M Sell
2,180,823
-35,826
-2% -$2.04M 0.31% 76
2018
Q4
$113M Sell
2,216,649
-601,383
-21% -$30.4M 0.28% 85
2018
Q3
$164M Buy
2,818,032
+84,318
+3% +$4.12M 0.34% 71
2018
Q2
$133M Buy
2,733,714
+885,339
+48% +$41.3M 0.28% 87
2018
Q1
$86M Sell
1,848,375
-30,627
-2% -$1.33M 0.18% 127
2017
Q4
$70.6M Sell
1,879,002
-62,196
-3% -$2.28M 0.15% 156
2017
Q3
$70.7M Sell
1,941,198
-29,649
-2% -$1.13M 0.15% 147
2017
Q2
$77.7M Sell
1,970,847
-1,547,361
-44% -$56.5M 0.17% 133
2017
Q1
$110M Sell
3,518,208
-2,862,240
-45% -$89.6M 0.25% 97
2016
Q4
$199M Sell
6,380,448
-1,490,865
-19% -$48.3M 0.48% 51
2016
Q3
$316K Sell
7,871,313
-189,831
-2% -$7.15M 0.6% 17
2016
Q2
$268M Buy
8,061,144
+91,440
+1% +$3.13M 0.66% 28
2016
Q1
$234M Sell
7,969,704
-762,534
-9% -$21M 0.58% 38
2015
Q4
$230M Sell
8,732,238
-1,829,364
-17% -$47.5M 0.56% 38
2015
Q3
$250M Buy
10,561,602
+1,958,526
+23% +$47.3M 0.63% 26
2015
Q2
$204M Buy
8,603,076
+7,729,086
+884% +$174M 0.47% 54
2015
Q1
$20.8M Sell
873,990
-108,966
-11% -$2.44M 0.05% 354
2014
Q4
$20.9M Buy
982,956
+187,212
+24% +$3.76M 0.05% 364
2014
Q3
$13.5M Buy
795,744
+279,930
+54% +$4.42M 0.03% 485
2014
Q2
$7.38M Sell
515,814
-8,550
-2% -$116K 0.02% 703
2014
Q1
$6.48M Sell
524,364
-17,340
-3% -$200K 0.02% 721
2013
Q4
$5.94M Sell
541,704
-9,738
-2% -$110K 0.01% 748
2013
Q3
$6.4M Sell
551,442
-24,576
-4% -$288K 0.02% 706
2013
Q2
$6.45M Buy
+576,018
New +$6.82M 0.02% 689

Other funds holding EW

VOYA Investment Management's EW Position: Q1 2026 in Review

VOYA Investment Management increased its Edwards Lifesciences (EW) stake by 0.19% in Q1 2026, buying an estimated $14.3K and bringing the position to 91,636 shares worth $7.34M. The position accounts for 0.01% of the portfolio, ranked #710.

VOYA Investment Management first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $318M in Q1 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • VOYA Investment Management held 91,636 shares of Edwards Lifesciences worth $7.34M as of Q1 2026.
  • VOYA Investment Management bought 174 Edwards Lifesciences shares in Q1 2026, an estimated $14.3K.
  • Edwards Lifesciences made up 0.01% of VOYA Investment Management's portfolio in Q1 2026, its #710 holding.
  • VOYA Investment Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
  • VOYA Investment Management's Edwards Lifesciences position peaked at $318M in Q1 2024.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.